IL6 and Obesity: Growing evidence reveals that the accumulation of adipose tissue leads to the development of systemic inflammation (e.g. increases in circulating levels of tumor necrosis factor-α and interleukin-6) [37, 38], which accounts for the obesity-associated vasculopathy and cardiovascular risks [39–41].